Sana Biotechnology (SANA) Treasury Shares (2020 - 2026)

Sana Biotechnology's Treasury Shares history runs 7 years deep, the most recent figure standing at $5.1 million for Q1 2026.

• In Q1 2026, Treasury Shares rose 14.66% year-over-year to $5.1 million; the TTM figure through Mar 2026 stood at $5.1 million (up 14.66% YoY), while the FY2025 annual figure was $3.8 million, up 7.23% from the prior year.
• Treasury Shares came in at $5.1 million for Q1 2026 at Sana Biotechnology, up from $3.8 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $5.1 million in Q1 2026 to a low of $885000.0 in Q4 2022.
• A 5-year average of $3.0 million and a median of $3.5 million in 2025 frame the typical range for Treasury Shares.
• Across the five-year window, Treasury Shares plunged 83.13% in 2022 and soared 167.52% in 2024, its largest moves.
• Sana Biotechnology's Treasury Shares stood at $885000.0 in 2022, then jumped by 164.52% to $2.3 million in 2023, then surged by 52.5% to $3.6 million in 2024, then increased by 7.23% to $3.8 million in 2025, then soared by 33.59% to $5.1 million in 2026.
• According to Business Quant data, Treasury Shares over the past three periods registered $5.1 million, $3.8 million, and $3.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison